| Elizabeth Danielle Davis, MS, OTR/L | |
|
440 Central Ave, Lexington, NC 27292-2634 | |
| (336) 236-6546 | |
| (336) 236-9546 |
| Full Name | Elizabeth Danielle Davis |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 440 Central Ave, Lexington, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063872745 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 10209 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Danielle Davis, MS, OTR/L Po Box 587, Lexington, NC 27293-0587 Ph: (336) 236-6546 | Elizabeth Danielle Davis, MS, OTR/L 440 Central Ave, Lexington, NC 27292-2634 Ph: (336) 236-6546 |
News Archive
Researchers at the University of Oslo have made discoveries that can have great consequences for the treatment of blindness caused by so-called limbal stem cell deficiency.
Early signs of Alzheimer's disease can be difficult to distinguish from the normal aging process in any older adult. For adults with Down syndrome, who are particularly vulnerable to Alzheimer's disease, it is even more so. Because effective intervention needs to begin as early in the disease process as possible, prior to the onset of the irreversible impacts on the brain that are characteristic of this devastating disease, early diagnosis is of critical importance. To address crucial gaps in knowledge about Alzheimer's disease in adults with Down syndrome, the Kennedy Krieger Institute has been awarded an $8.5 million grant from the National Institutes of Health (NIH).
Amgen (Nasdaq: AMGN) today announced detailed results from a Phase 3, head-to-head trial evaluating denosumab versus Zometa(R) (zoledronic acid) in the treatment of bone metastases in 2,046 patients with advanced breast cancer that met its primary and secondary endpoints and demonstrated superior efficacy compared to Zometa.
The National Comprehensive Cancer Network-an alliance of leading cancer centers-has published new best practice recommendations for Management of COVID-19 Infection in Patients with Cancer.
› Verified 2 days ago
Stacie Howard Anuszkiewicz, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 877 Hill Everhart Rd, Lexington, NC 27295 Phone: 336-264-6644 | |
Amber T Goode, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 440 Central Ave, Lexington, NC 27292 Phone: 336-236-6546 Fax: 236-236-9546 | |
Joanne Brown, COTA/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 877 Hill Everhart Rd, Lexington, NC 27295 Phone: 336-248-6644 | |
Stephanie Hodges Howell, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 440 Central Ave, Lexington, NC 27292 Phone: 336-236-6546 Fax: 336-236-9546 | |
Katrina Mavrode, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 614 Cardinal Dr, Lexington, NC 27292 Phone: 336-843-1420 | |
Amy Marie Yow, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 440 Central Ave, Lexington, NC 27292 Phone: 336-236-6546 Fax: 336-236-9546 |